TSS
CNTA

Two Sigma Securities’s Centessa Pharmaceuticals CNTA Stock Holding History

Two Sigma Securities’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,917
Closed -$526K – 1921
2024
Q3 		$526K Buy
+32,917
New +$403K 0.01% 1282

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Securities's CNTA Position: Q4 2024 in Review

Two Sigma Securities sold out of Centessa Pharmaceuticals (CNTA) in Q4 2024, closing a stake of 32,917 shares — an estimated $526K sold.

Two Sigma Securities first reported a position in CNTA in Q3 2024 and held it in 1 quarter. The position peaked at $526K in Q3 2024. 114 funds tracked by Wall St. Rank hold CNTA as of Q4 2024.

  • Two Sigma Securities reported no remaining Centessa Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 32,917 Centessa Pharmaceuticals shares in Q4 2024, an estimated $526K.
  • Two Sigma Securities first reported a position in Centessa Pharmaceuticals in Q3 2024 and held it in 1 quarter.
  • Two Sigma Securities's Centessa Pharmaceuticals position peaked at $526K in Q3 2024.
  • 114 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.